Atif J Khan Selected Research

Atif J Khan Research Topics

39	Breast Neoplasms (Breast Cancer) 10/2022 - 04/2002
27	Neoplasms (Cancer) 01/2022 - 09/2005
4	Neoplasm Metastasis (Metastasis) 02/2020 - 12/2016
4	Brain Neoplasms (Brain Tumor) 11/2018 - 04/2011
3	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2021 - 12/2013
3	Infections 07/2020 - 09/2009
2	Second Primary Neoplasms (Neoplasms, Second) 01/2021 - 04/2002
2	Cicatrix (Scar) 01/2020 - 06/2017
2	Fatigue 01/2020 - 09/2011
2	Glioma (Gliomas) 04/2019 - 05/2018
2	Medulloblastoma 10/2017 - 12/2016
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 05/2017 - 02/2017
2	Cardiovascular Diseases (Cardiovascular Disease) 07/2014 - 01/2014
2	Cardiotoxicity 01/2014 - 01/2014
1	Triple Negative Breast Neoplasms 04/2022
1	Ovarian Neoplasms (Ovarian Cancer) 01/2022
1	Mastodynia 12/2021
1	COVID-19 07/2020
1	Hypersensitivity (Allergy) 01/2020
1	Lymphedema (Milroy Disease) 01/2020
1	Pain (Aches) 01/2020
1	Inflammatory Breast Neoplasms 07/2019
1	Glioblastoma (Glioblastoma Multiforme) 04/2019
1	Carcinoma (Carcinomatosis) 02/2017
1	Central Nervous System Neoplasms 01/2017
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2016
1	Hodgkin Disease (Hodgkin's Disease) 08/2014
1	Necrosis 06/2014
1	Unilateral Breast Neoplasms 01/2014
1	Wounds and Injuries (Trauma) 04/2013
1	Dermatitis 01/2012
1	Hyperpigmentation 01/2012
1	Melanoma (Melanoma, Malignant) 04/2011
1	Wound Infection (Wound Infections) 09/2009
1	Vomiting 01/2009
1	Nausea 01/2009
1	Ductal Carcinoma 11/2008
1	Fibrosis (Cirrhosis) 09/2005
1	Lung Neoplasms (Lung Cancer) 09/2005

7	Hormones (Hormone)IBA 04/2022 - 09/2011
4	Estrogen ReceptorsIBA 01/2021 - 01/2018
3	Protons (Proton)IBA 12/2021 - 05/2016
3	Estrogens (Estrogen)FDA Link 01/2021 - 07/2015
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2021
2	Progesterone Receptors (Progesterone Receptor)IBA 01/2021 - 01/2019
2	Riluzole FDA LinkGeneric 04/2019 - 04/2011
2	Glutamic Acid (Glutamate)FDA Link 04/2019 - 04/2011
2	Biomarkers (Surrogate Marker)IBA 07/2014 - 01/2014
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022
1	PlatinumIBA 01/2022
1	ErbB Receptors (EGF Receptor)IBA 01/2021
1	Aromatase InhibitorsIBA 07/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	metabotropic glutamate receptor 3 (mGluR3)IBA 04/2019
1	Proteins (Proteins, Gene)FDA Link 04/2019
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 05/2018
1	AnthracyclinesIBA 01/2014
1	TroponinIBA 01/2014
1	Tamoxifen FDA LinkGeneric 09/2013
1	pazopanib FDA Link 01/2012
1	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 04/2011
1	Iodine-125IBA 03/2010
1	Palonosetron (Aloxi)FDA Link 01/2009
1	AntiemeticsIBA 01/2009
1	Yttrium-90IBA 01/2009

39	Radiotherapy 10/2022 - 04/2002
18	Therapeutics 01/2021 - 04/2002
15	Segmental Mastectomy (Lumpectomy) 12/2021 - 04/2002
12	Drug Therapy (Chemotherapy) 01/2022 - 09/2005
9	Brachytherapy 01/2019 - 11/2008
7	Mastectomy (Mammectomy) 12/2021 - 03/2014
4	Proton Therapy 10/2019 - 05/2016
3	Aftercare (After-Treatment) 10/2019 - 04/2011
2	Re-Irradiation 12/2021 - 07/2021
2	Adjuvant Chemotherapy 01/2021 - 12/2016
2	Adjuvant Radiotherapy 10/2012 - 01/2012
1	Immunotherapy 01/2020
1	Neoadjuvant Therapy 12/2018
1	Lasers (Laser) 06/2014
1	Laser Therapy (Surgery, Laser) 06/2014
1	Catheters 09/2009
1	Patient Readmission 01/2009
1	Chemoprevention 04/2002